Definitive Healthcare welcomes Monocl
Data-powered clinical development and commercialisation.
30 October 2020 - Definitive Healthcare, the leading provider of data, intelligence and analytics on the healthcare market, announced its acquisition of Monocl, the leading subscription-based provider of medical and scientific expert data and insights.

Monocl delivers deep professional profiles on millions of experts worldwide, to help companies identify and engage industry opinion leaders. Through the transaction, Definitive fortifies its product offerings for life sciences companies and expands its international presence from North America to Europe and Asia.

“Monocl has always been laser focused on delivering critical expert insights through software to provide our clients with a unique competitive and collaborative edge,” said Björn Carlsson, CEO and co-founder of Monocl. “We are thrilled to unite the power of our groundbreaking expert platform with Definitive’s comprehensive and complementary healthcare provider platform and medical claims analytics. This is truly an example of the whole being much greater than the sum of its parts.”

“The acquisition of Monocl brings together two powerful intelligence platforms to provide best-in-class data, analytics and insight that will help biotech and pharmaceutical companies accelerate clinical research and commercialisation of new drugs and therapies,” said Jason Krantz, founder and CEO of Definitive Healthcare. “Monocl shares the Definitive philosophy of providing the highest quality data through an online interface that gives clients the ability to access and analyse real-time information and intelligence.”

Joakim Dal, Partner at GP Bullhound, added: “Björn and his team have put a very powerful application in the hands of Monocl’s customers. The superior user interface and the vast data library makes this a standard for enterprise applications. During our investment period, Monocl has developed at a rapid pace. We look forward to what the combination of these two leading companies can do to support the critical work in the life sciences sector.”

GP Bullhound invested in Monocl in 2019 through GP Bullhound Fund IV, which focuses on growth stage businesses in the software, digital media, marketplaces and fintech sectors. Other investments include Revolut, Slack, Klarna, Unity, RavenPack and Believe.

Enquiries
For enquiries, please contact:
Joakim Dal, Partner, at joakim.dal@gpbullhound.com

About GP Bullhound
GP Bullhound is a leading technology advisory and investment firm, providing transaction advice and capital to the world’s best entrepreneurs and founders. Founded in 1999, the firm today has offices in London, San Francisco, Stockholm, Berlin, Manchester, Paris, Hong Kong, Madrid and New York. For more information, please visit www.gpbullhound.com.

Sector
Software